BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34850014)

  • 21. Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study.
    Gullstrand C; Wahlberg J; Ilonen J; Vaarala O; Ludvigsson J
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):182-90. PubMed ID: 18331414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany.
    Kordonouri O; Hartmann R; Charpentier N; Knip M; Danne T; Ilonen J
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):245-9. PubMed ID: 20140847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
    Barker JM; Barriga KJ; Yu L; Miao D; Erlich HA; Norris JM; Eisenbarth GS; Rewers M;
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3896-902. PubMed ID: 15292324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proinsulin:C-peptide ratio trajectories over time in relatives at increased risk of progression to type 1 diabetes.
    Triolo TM; Pyle L; Seligova S; Yu L; Simmons K; Gottlieb P; Evans-Molina C; Steck AK
    J Transl Autoimmun; 2021; 4():100089. PubMed ID: 33748733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls.
    Noble JA; Martin A; Valdes AM; Lane JA; Galgani A; Petrone A; Lorini R; Pozzilli P; Buzzetti R; Erlich HA
    Hum Immunol; 2008; 69(4-5):291-300. PubMed ID: 18486765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes.
    Jia X; He L; Miao D; Waugh K; Rasmussen CG; Dong F; Steck AK; Rewers M; Yu L
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3455-3463. PubMed ID: 34343303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease.
    Lind A; de Jesus Cortez F; Ramelius A; Bennet R; Robinson PV; Seftel D; Gebhart D; Tandel D; Maziarz M; Agardh D; Larsson HE; Lundgren M; Tsai CT; Lernmark Å
    J Immunol Methods; 2022 Jul; 506():113265. PubMed ID: 35358496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.
    Kozhakhmetova A; Wyatt RC; Caygill C; Williams C; Long AE; Chandler K; Aitken RJ; Wenzlau JM; Davidson HW; Gillespie KM; Williams AJK
    Clin Exp Immunol; 2018 Jun; 192(3):251-258. PubMed ID: 29431870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between deduced first islet specific autoantibody with sex, age at diagnosis and genetic risk factors in young children with type 1 diabetes.
    Ilonen J; Laine AP; Kiviniemi M; Härkönen T; Lempainen J; Knip M;
    Pediatr Diabetes; 2022 Sep; 23(6):693-702. PubMed ID: 35403376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
    Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
    BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
    Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.
    Li H; Lindholm E; Almgren P; Gustafsson A; Forsblom C; Groop L; Tuomi T
    J Clin Endocrinol Metab; 2001 Feb; 86(2):574-82. PubMed ID: 11158011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes.
    Ziegler R; Alper CA; Awdeh ZL; Castano L; Brink SJ; Soeldner JS; Jackson RA; Eisenbarth GS
    Diabetes; 1991 Jun; 40(6):709-14. PubMed ID: 2040387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes.
    Thomas NJ; Walkey HC; Kaur A; Misra S; Oliver NS; Colclough K; Weedon MN; Johnston DG; Hattersley AT; Patel KA
    Diabetologia; 2023 Feb; 66(2):310-320. PubMed ID: 36355183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.
    Krischer JP; Lynch KF; Schatz DA; Ilonen J; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Simell OG; Toppari J; Ziegler AG; Akolkar B; Bonifacio E;
    Diabetologia; 2015 May; 58(5):980-7. PubMed ID: 25660258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients.
    Gabbay MA; Sato MN; Duarte AJ; Dib SA
    Clin Exp Immunol; 2012 Apr; 168(1):60-7. PubMed ID: 22385239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Millennium award recipient contribution. Identification of children with early onset and high incidence of anti-islet autoantibodies.
    Robles DT; Eisenbarth GS; Wang T; Erlich HA; Bugawan TL; Babu SR; Barriga K; Norris JM; Hoffman M; Klingensmith G; Yu L; Rewers M;
    Clin Immunol; 2002 Mar; 102(3):217-24. PubMed ID: 11890708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two subsets of HLA-DQA1 alleles mark phenotypic variation in levels of insulin autoantibodies in first degree relatives at risk for insulin-dependent diabetes.
    Pugliese A; Bugawan T; Moromisato R; Awdeh ZL; Alper CA; Jackson RA; Erlich HA; Eisenbarth GS
    J Clin Invest; 1994 Jun; 93(6):2447-52. PubMed ID: 8200980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
    Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
    Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.